• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

惊恐障碍患者胆囊收缩素系统的基因变异

Gene variations in the cholecystokinin system in patients with panic disorder.

作者信息

Koefoed Pernille, Woldbye David P, Hansen Thomas O, Hansen Elsebeth S, Knudsen Gitte M, Bolwig Tom G, Rehfeld Jens F

机构信息

Laboratory for Neuropsychiatry, Department of Neuroscience and Pharmacology, University of Copenhagen, Denmark.

出版信息

Psychiatr Genet. 2010 Apr;20(2):59-64. doi: 10.1097/YPG.0b013e32833511a8.

DOI:10.1097/YPG.0b013e32833511a8
PMID:20023595
Abstract

OBJECTIVES

Panic disorder (PD) is a common psychiatric disease occurring more frequently in women than men. Multiple common and/or rare variants in the genome contribute to the complex etiology of the disorder. The neuropeptide cholecystokinin (CCK) and its receptors (the CCK system) have been suggested to be involved in the pathogenesis of PD.

METHODS

We examined the promoter, exon, and exon-intron boundaries of the genes encoding CCK and its receptors (CCKAR and CCKBR) for variations in 187 patients with PD and 277 screened control individuals. Up to 1342 additional healthy population controls were examined for some of the variations. One CCK gene intron variation was analyzed for alternative splicing using an exon-trapping assay.

RESULTS

The promoter variant (-36C > T; rs1799923) and an intron 1 polymorphism (IVS1-7C > G; rs754635) in the CCK gene were found to protect against PD (P<0.05). The intron 1 variation did not seem to alter the splicing of the gene. None of the other variations found were associated with PD, but a 2-marker haplotype (rs1800855/rs1800857) in the CCKAR gene protected women against PD (P=0.004). In addition, we found two novel rare missense variations in the CCKBR gene (Lys329Asn and Pro446Leu) in two and one patient, respectively.

CONCLUSION

The results suggest that the CCK system may play a role in the pathogenesis of PD, with susceptibility alleles both protecting and contributing to the disease. Both common and rare variants seem to be involved. The involvement of the CCK system may also contribute to the increased prevalence of PD in women.

摘要

目的

惊恐障碍(PD)是一种常见的精神疾病,女性比男性更易发病。基因组中的多个常见和/或罕见变异导致了该疾病复杂的病因。有研究表明神经肽胆囊收缩素(CCK)及其受体(CCK系统)参与了PD的发病机制。

方法

我们检测了187例PD患者和277例筛查对照个体中编码CCK及其受体(CCKAR和CCKBR)的基因的启动子、外显子和外显子-内含子边界的变异情况。对另外1342名健康人群对照进行了部分变异检测。使用外显子捕获试验分析了一个CCK基因内含子变异的可变剪接情况。

结果

发现CCK基因的启动子变异(-36C>T;rs1799923)和内含子1多态性(IVS1-7C>G;rs754635)可预防PD(P<0.05)。内含子1变异似乎未改变该基因的剪接。其他所发现的变异均与PD无关,但CCKAR基因中的一个双标记单倍型(rs1800855/rs1800857)可保护女性预防PD(P=0.004)。此外,我们分别在两名和一名患者中发现了CCKBR基因中的两个新的罕见错义变异(Lys329Asn和Pro446Leu)。

结论

结果表明CCK系统可能在PD的发病机制中起作用,易感性等位基因既具有保护作用又会导致疾病发生。常见和罕见变异似乎均有涉及。CCK系统的参与可能也导致了PD在女性中患病率的增加。

相似文献

1
Gene variations in the cholecystokinin system in patients with panic disorder.惊恐障碍患者胆囊收缩素系统的基因变异
Psychiatr Genet. 2010 Apr;20(2):59-64. doi: 10.1097/YPG.0b013e32833511a8.
2
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.有幻觉和无幻觉帕金森病患者的基因多态性:胆囊收缩素系统分析
Arch Neurol. 2004 Aug;61(8):1280-4. doi: 10.1001/archneur.61.8.1280.
3
Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.特发性环境不耐受:与惊恐障碍相关的胆囊收缩素B受体等位基因7的患病率增加。
J Allergy Clin Immunol. 2001 May;107(5):887-90. doi: 10.1067/mai.2001.114798.
4
Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.惊恐障碍的神经网络:神经肽胆囊收缩素的作用。
Depress Anxiety. 2012 Sep;29(9):762-74. doi: 10.1002/da.21919. Epub 2012 May 2.
5
Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder.胆囊收缩素B受体基因的错义突变:与惊恐障碍无关。
Am J Med Genet. 1996 Jul 26;67(4):401-5. doi: 10.1002/(SICI)1096-8628(19960726)67:4<401::AID-AJMG14>3.0.CO;2-N.
6
Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism.对CCKAR基因中与酒精成瘾易感性相关的数量性状基因座的研究。
Alcohol Clin Exp Res. 2002 Aug;26(8 Suppl):2S-5S. doi: 10.1097/01.ALC.0000026826.96191.FB.
7
Identification of a compound short tandem repeat stretch in the 5'-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia.胆囊收缩素基因5'-上游区域复合短串联重复序列片段的鉴定及其与惊恐障碍而非精神分裂症的关联。
Mol Psychiatry. 2001 Jul;6(4):465-70. doi: 10.1038/sj.mp.4000875.
8
Investigation of cholecystokinin system genes in panic disorder.惊恐障碍中胆囊收缩素系统基因的研究。
Mol Psychiatry. 1999 May;4(3):284-5. doi: 10.1038/sj.mp.4000507.
9
Cholecystokinin and panic disorder: past and future clinical research strategies.胆囊收缩素与惊恐障碍:过去及未来的临床研究策略
Scand J Clin Lab Invest Suppl. 2001;234:19-27.
10
Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.在健康志愿者中使用CCK - 4激发试验对惊恐障碍候选基因进行关联测试。
Neurosci Lett. 2008 Dec 3;446(2-3):88-92. doi: 10.1016/j.neulet.2008.09.052.

引用本文的文献

1
Evaluation of MINOCA syndrome and HEART score in patients presenting to the emergency department with panic attack and chest pain complaints.MINOCA 综合征与 HEART 评分在以惊恐发作和胸痛为主诉就诊于急诊科患者中的评估。
Ir J Med Sci. 2022 Oct;191(5):2351-2356. doi: 10.1007/s11845-022-03018-6. Epub 2022 Apr 28.
2
Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions.胆囊收缩素与惊恐障碍:历史反思与未解问题探讨。
Molecules. 2021 Sep 17;26(18):5657. doi: 10.3390/molecules26185657.
3
Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans.
探索胆囊收缩素启动子多态性(rs1799923)与退伍军人创伤后应激障碍之间的关联。
J Anxiety Disord. 2015 Dec;36:78-83. doi: 10.1016/j.janxdis.2015.09.009. Epub 2015 Sep 28.
4
Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.惊恐障碍的候选基因:主要焦虑途径中 23 个常见变异的荟萃分析。
Mol Psychiatry. 2016 May;21(5):665-79. doi: 10.1038/mp.2015.138. Epub 2015 Sep 22.
5
Drug addiction and stress-response genetic variability: association study in African Americans.药物成瘾与应激反应基因变异性:非裔美国人的关联研究
Ann Hum Genet. 2014 Jul;78(4):290-8. doi: 10.1111/ahg.12064. Epub 2014 Apr 26.
6
Variants in CCK and CCKAR genes to susceptibility to biliary tract cancers and stones: a population-based study in Shanghai, China.胆囊收缩素(CCK)和胆囊收缩素受体(CCKAR)基因变异与胆道癌和结石易感性的关系:中国上海的一项基于人群的研究。
J Gastroenterol Hepatol. 2013 Sep;28(9):1476-81. doi: 10.1111/jgh.12278.
7
Replication and meta-analysis of TMEM132D gene variants in panic disorder.TMEM132D 基因变异与惊恐障碍的复制与荟萃分析。
Transl Psychiatry. 2012 Sep 4;2(9):e156. doi: 10.1038/tp.2012.85.
8
A genome-wide study of panic disorder suggests the amiloride-sensitive cation channel 1 as a candidate gene.一项关于惊恐障碍的全基因组研究表明,阿米洛利敏感的阳离子通道 1 是候选基因。
Eur J Hum Genet. 2012 Jan;20(1):84-90. doi: 10.1038/ejhg.2011.148. Epub 2011 Aug 3.
9
The genetic basis of panic disorder.惊恐障碍的遗传学基础。
J Korean Med Sci. 2011 Jun;26(6):701-10. doi: 10.3346/jkms.2011.26.6.701. Epub 2011 May 18.
10
The norepinephrine transporter gene is a candidate gene for panic disorder.去甲肾上腺素转运体基因是惊恐障碍的候选基因。
J Neural Transm (Vienna). 2011 Jun;118(6):969-76. doi: 10.1007/s00702-011-0624-7. Epub 2011 Mar 18.